CPI’s Intracellular Drug Delivery Centre: Data-driven RNA-LNP formulation design

Discover how data-driven RNA-LNP formulation design accelerates optimisation, improves delivery performance and advances next-generation RNA therapies.

From Automation to Optimisation: Data Driven RNA LNP Formulation Design presentation cover.

At CPI’s Intracellular Drug Delivery Centre, we’re pioneering data-driven approaches that accelerate the design and optimisation of RNA-lipid nanoparticle (RNA-LNP) formulations. With cutting-edge screening, formulation, and manufacturing capabilities, we help industry and academic partners overcome critical challenges in delivery science.

Download Juliana Haggerty’s presentation, delivered at the RNA Vaccines and Therapeutics Conference 2025, to explore real-world case studies that show how data and experimentation combine to drive innovation:

Buffer optimisation – Can we make smaller diameter particles using pipette mixing, while retaining performance?
Neutral Lipid effect, a “DOPE” story – Uncovering how neutral lipids influence transfection efficiency.
Biodegradable C12-200 to reduce cytotoxicity – Designing safer formulations without compromising performance.

Fill out the form to access the full presentation and see how CPI’s expertise in RNA-LNP formulation design can help you bring breakthrough therapies closer to patients.

Get the guide

Related guides

A practical guide to using life cycle assessments (LCA) for sustainable process development

Coating technologies for fibre packaging

From bench to clinic: ten ways CPI de-risks and accelerates viral vector and viral vaccine development

A practical guide to using life cycle assessments (LCA) for sustainable process development

Coating technologies for fibre packaging

A practical guide to using life cycle assessments (LCA) for sustainable process development

Coating technologies for fibre packaging